Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. The Worldwide Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphological, scientific, and genomic knowledge. Blood. 2022;140:1200–28.
Gangat N, Tefferi A. Myeloproliferative neoplasms and being pregnant: overview and observe suggestions. Am J Hematol. 2021;96:354–66.
Hultcrantz M, Ravn Landtblom A, Andreasson B, Samuelsson J, Dickman PW, Kristinsson SY, et al. Incidence of myeloproliferative neoplasms—traits by subgroup and age in a population-based research in Sweden. J Intern Med. 2020;287:448–54.
Robinson SE, Harrison CN. How we handle Philadelphia-negative myeloproliferative neoplasms in being pregnant. Br J Haematol. 2020;189:625–34.
Skeith L, Provider M, Robinson SE, Alimam S, Rodger MA. Threat of venous thromboembolism in pregnant ladies with important thrombocythemia: a scientific overview and meta-analysis. Blood. 2017;129:934–9.
Griesshammer M, Sadjadian P, Wille Ok. Up to date administration of sufferers with BCR-ABL1-negative myeloproliferative neoplasms throughout being pregnant. Skilled Rev Hematol. 2018;11:697–706.
Landtblom AR, Andersson TM, Johansson ALV, Wendel SB, Lundberg FE, Samuelsson J, et al. Being pregnant and childbirth outcomes in ladies with myeloproliferative neoplasms-a nationwide population-based research of 342 pregnancies in Sweden. Leukemia. 2022;36:2461–7.
Alimam S, Bewley S, Chappell LC, Knight M, Seed P, Grey G, et al. Being pregnant outcomes in myeloproliferative neoplasms: UK potential cohort research. Br J Haematol. 2016;175:31–6.
Bao M, Zhang M, Shi H, Liu X, Duan M, Zhuang J, et al. Affected person-reported outcomes in younger adults with myeloproliferative neoplasms. Acta Haematol. 2023;146:293–306.
Armuand GM, Wettergren L, Rodriguez-Wallberg KA, Lampic C. Want for youngsters, difficulties attaining a being pregnant, and infertility misery 3 to 7 years after most cancers analysis. Help Care Most cancers. 2014;22:2805–12.
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish private id quantity: potentialities and pitfalls in healthcare and medical analysis. Eur J Epidemiol. 2009;24:659–67.
Barlow L, Westergren Ok, Holmberg L, Talback M. The completeness of the Swedish Most cancers Register: a pattern survey for yr 1998. Acta Oncol. 2009;48:27–33.
Turesson I, Linet MS, Bjorkholm M, Kristinsson SY, Goldin LR, Caporaso NE, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J most cancers J Int du most cancers. 2007;121:2260–6.
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. Exterior overview and validation of the Swedish nationwide inpatient register. BMC Public Well being. 2011;11:450.
Socialstyrelsen. Utvärdering av det svenska Medicinska födelseregistret. 2002. Report No.: 2002-112-4.
Ekbom A. The Swedish multi-generation register. In: Dillner J, editor. Strategies in biobanking. Totowa, NJ: Humana Press; 2011. p. 215–20.
Deshpande NA, Braun IM, Meyer FL. Affect of fertility preservation counseling and therapy on psychological outcomes amongst ladies with most cancers: a scientific overview. Most cancers. 2015;121:3938–47.
Socialstyrelsen. Statistik om graviditeter, förlossningar och nyfödda barn 2020. 2021 2021-12-01. Contract No.: 2021-12-7651.
Hultcrantz M, Andersson TM-L, Landgren O, Derolf AR, Dickman PW, Björkholm M, et al. Threat of arterial and venous thrombosis in 11,155 sufferers with myeloproliferative neoplasms and 44,620 matched controls; a population-based research. Blood. 2014;124:632.
Hultcrantz M, Kristinsson SY, Andersson TM, Landgren O, Eloranta S, Derolf AR, et al. Patterns of survival amongst sufferers with myeloproliferative neoplasms identified in Sweden from 1973 to 2008: a population-based research. J Clin Oncol. 2012;30:2995–3001.
Hultcrantz M, Wilkes SR, Kristinsson SY, Andersson TM, Derolf AR, Eloranta S, et al. Threat and reason behind dying in sufferers identified with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based research. J Clin Oncol. 2015;33:2288–95.
Lindgren M, Scheding S, Ahlstrand E, Andreasson B, Ravn Landtblom A, Liljeholm M, et al. Nationellt vårdprogram för myeloproliferativ neoplasi (MPN). ed: Regionala cancercentrum i samverkan; 2020.
Andreasson B, Lofvenberg E, Westin J. Administration of sufferers with polycythaemia vera: outcomes of a survey amongst Swedish haematologists. Eur J Haematol. 2005;74:489–95.
Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, et al. Affiliation of therapies for myeloproliferative neoplasms throughout being pregnant with delivery charges and maternal outcomes: a scientific overview and meta-analysis. JAMA Netw Open. 2019;2:e1912666.
Zhang M, Fu S, Ren D, Wu Y, Yao N, Ni T, et al. Maternal and fetal outcomes after interferon publicity throughout being pregnant: a scientific overview with meta-analysis. Entrance Reprod Well being. 2021;3:702929.
Waysbort A, Giroux M, Mansat V, Teixeira M, Dumas JC, Puel J. Experimental research of transplacental passage of alpha interferon by two assay methods. Antimicrob Brokers Chemother. 1993;37:1232–7.
Ozturk O, Greaves M, Templeton A. Aspirin dilemma: remodelling the speculation from a fertility perspective. Hum Reprod. 2002;17:1146–8.
Jukic AMZ, Padiyara P, Bracken MB, McConnaughey DR, Steiner AZ. Analgesic use at ovulation and implantation and human fertility. Am J Obstet Gynecol. 2020;222:476.e1–e11.
Miyakis S, Lockshin MD, Atsumi T, Department DW, Brey RL, Cervera R, et al. Worldwide consensus assertion on an replace of the classification standards for particular antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.
Melillo L, Tieghi A, Candoni A, Radaelli F, Ciancia R, Specchia G, et al. Consequence of 122 pregnancies in important thrombocythemia sufferers: a report from the Italian registry. Am J Hematol. 2009;84:636–40.
Robinson S, Bewley S, Hunt BJ, Radia DH, Harrison CN. The administration and consequence of 18 pregnancies in ladies with polycythemia vera. Haematologica 2005;90:1477–83.
Griesshammer M, Andreoli A, Schauer S, Gotic M, Barbui T, Dohner Ok, et al. Outcomes of 121 pregnancies in sufferers with polycythemia vera (PV). Haematologica 2016;101:6.
Bertozzi I, Rumi E, Cavalloni C, Cazzola M, Fabris F, Randi ML. Being pregnant consequence and administration of 25 pregnancies in ladies with polycythemia vera. Am J Hematol. 2018;93:E234–E5.
Linnakaari R, Helle N, Mentula M, Bloigu A, Gissler M, Heikinheimo O, et al. Developments within the incidence, charge and therapy of miscarriage—nationwide register-study in Finland, 1998–2016. Hum Reprod. 2019;34:2120–8.
